(CHWY) Chewy - Overview

Sector: Consumer Cyclical | Industry: Internet Retail | Exchange: NYSE (USA) | Market Cap: 8.744m USD | Total Return: -53.1% in 12m

Pet Food, Pet Supplies, Medications, Pet Services
Total Rating 31
Safety 30
Buy Signal -0.49
Internet Retail
Industry Rotation: +2.6
Market Cap: 8.74B
Avg Turnover: 185M
Risk 3d forecast
Volatility51.4%
VaR 5th Pctl8.52%
VaR vs Median0.61%
Reward TTM
Sharpe Ratio-1.38
Rel. Str. IBD2.5
Rel. Str. Peer Group15.6
Character TTM
Beta0.919
Beta Downside0.957
Hurst Exponent0.424
Drawdowns 3y
Max DD63.01%
CAGR/Max DD-0.25
CAGR/Mean DD-0.48
EPS (Earnings per Share) EPS (Earnings per Share) of CHWY over the last years for every Quarter: "2021-04": 0.09, "2021-07": -0.04, "2021-10": -0.07, "2022-01": -0.15, "2022-04": 0.05, "2022-07": 0.05, "2022-10": 0.01, "2023-01": 0.01, "2023-04": 0.2, "2023-07": 0.15, "2023-10": 0.15, "2024-01": 0.18, "2024-04": 0.15, "2024-07": 0.24, "2024-10": 0.01, "2025-01": 0.28, "2025-04": 0.35, "2025-07": 0.33, "2025-10": 0.32, "2026-01": 0.27,
EPS CAGR: 60.90%
EPS Trend: 93.3%
Last SUE: -0.18
Qual. Beats: 0
Revenue Revenue of CHWY over the last years for every Quarter: 2021-04: 2135.178, 2021-07: 2155.036, 2021-10: 2212.161, 2022-01: 2388.398, 2022-04: 2428.327, 2022-07: 2431.011, 2022-10: 2532.122, 2023-01: 2707.479, 2023-04: 2790.639, 2023-07: 2785.302, 2023-10: 2745.875, 2024-01: 2846.665, 2024-04: 2877.7, 2024-07: 2858.589, 2024-10: 2877.635, 2025-01: 3247.386, 2025-04: 3116, 2025-07: 3104.2, 2025-10: 3116.6, 2026-01: 3264.7,
Rev. CAGR: 6.90%
Rev. Trend: 98.8%
Last SUE: -0.10
Qual. Beats: 0

Warnings

Altman Z'' -1.63 < 1.0 - financial distress zone

Below Avwap Earnings

Tailwinds

No distinct edge detected

Description: CHWY Chewy

Chewy, Inc. is a leading e-commerce retailer specializing in pet food, supplies, and healthcare products within the United States. The company operates through a digital-first model, utilizing its proprietary websites and mobile applications to distribute a wide range of pet-related goods and professional services.

A core component of the business model is the Autoship subscription program, which generates recurring revenue by automating the delivery of essential pet consumables. This reflects a broader trend in the specialty retail sector where high-frequency, low-volatility purchases are increasingly shifting from brick-and-mortar locations to direct-to-consumer platforms.

The company expanded its addressable market by integrating pet health services and medications into its ecosystem, leveraging the high consumer loyalty inherent in the pet care industry. For a deeper look into the companys fundamentals, you may find it useful to explore more data on ValueRay.

Headlines to Watch Out For
  • Autoship subscription program growth drives predictable recurring revenue and customer retention
  • Expansion of high-margin pet health services and pharmacy offerings improves profitability
  • Active customer base stabilization and growth trends dictate long-term market valuation
  • Logistics and fulfillment efficiency gains reduce shipping costs to expand operating margins
  • Discretionary consumer spending levels impact premium pet food and hard goods sales volume
Piotroski VR-10 (Strict) 5.0
Net Income: 222.8m TTM > 0 and > 6% of Revenue
FCF/TA: 0.16 > 0.02 and ΔFCF/TA 0.64 > 1.0
NWC/Revenue: -2.11% < 20% (prev -4.59%; Δ 2.48% < -1%)
CFO/TA 0.19 > 3% & CFO 691.6m > Net Income 222.8m
Net Debt (196.7m) to EBITDA (397.3m): 0.50 < 3
Current Ratio: 0.88 > 1.5 & < 3
Outstanding Shares: last quarter (424.1m) vs 12m ago -1.60% < -2%
Gross Margin: 29.79% > 18% (prev 0.29%; Δ 2.95k% > 0.5%)
Asset Turnover: 381.4% > 50% (prev 393.5%; Δ -12.08% > 0%)
Interest Coverage Ratio: 57.02 > 6 (EBITDA TTM 397.3m / Interest Expense TTM 4.70m)
Altman Z'' -1.63
A: -0.07 (Total Current Assets 2.04b - Total Current Liabilities 2.30b) / Total Assets 3.59b
B: -0.38 (Retained Earnings -1.36b / Total Assets 3.59b)
C: 0.08 (EBIT TTM 268.0m / Avg Total Assets 3.30b)
D: -0.44 (Book Value of Equity -1.35b / Total Liabilities 3.10b)
Altman-Z'' = -1.63 = D
Beneish M -2.74
DSRI: 1.24 (Receivables 222.2m/169.0m, Revenue 12.6b/11.9b)
GMI: 0.98 (GM 29.79% / 29.24%)
AQI: 1.33 (AQ_t 0.15 / AQ_t-1 0.11)
SGI: 1.06 (Revenue 12.6b / 11.9b)
TATA: -0.13 (NI 222.8m - CFO 691.6m) / TA 3.59b)
Beneish M = -2.74 (Cap -4..+1) = A
What is the price of CHWY shares?

As of June 03, 2026, the stock is trading at USD 22.28 with a total of 7,866,270 shares traded.
Over the past week, the price has changed by +7.48%, over one month by -12.76%, over three months by -17.69% and over the past year by -53.06%.

Is CHWY a buy, sell or hold?

Chewy has received a consensus analysts rating of 3.90. Therefore, it is recommended to buy CHWY.

  • StrongBuy: 11
  • Buy: 6
  • Hold: 12
  • Sell: 1
  • StrongSell: 0

What are the forecasts/targets for the CHWY price?
Analysts Target Price 39.9 78.9%
Chewy (CHWY) - Fundamental Data Overview as of 30 May 2026
Market Cap USD = 8.74b (8.74b USD * 1.0 USD.USD)
P/E Trailing = 41.1154
P/E Forward = 14.245
P/S = 0.6939
P/B = 17.5619
P/EG = 0.373
Revenue TTM = 12.6b USD
EBIT TTM = 268.0m USD
EBITDA TTM = 397.3m USD
Long Term Debt = 518.7m USD (estimated: total debt 556.8m - short term 38.1m)
Short Term Debt = 38.1m USD (from shortTermDebt, last quarter)
Debt = 1.08b USD (from shortLongTermDebtTotal, last quarter) + Leases 518.7m
Net Debt = 196.7m USD (calculated: Debt 1.08b - CCE 878.8m)
Enterprise Value = 8.94b USD (8.74b + Debt 1.08b - CCE 878.8m)
Interest Coverage Ratio = 57.02 (Ebit TTM 268.0m / Interest Expense TTM 4.70m)
EV/FCF = 15.90x (Enterprise Value 8.94b / FCF TTM 562.4m)
FCF Yield = 6.29% (FCF TTM 562.4m / Enterprise Value 8.94b)
FCF Margin = 4.46% (FCF TTM 562.4m / Revenue TTM 12.6b)
Net Margin = 1.77% (Net Income TTM 222.8m / Revenue TTM 12.6b)
Gross Margin = 29.79% ((Revenue TTM 12.6b - Cost of Revenue TTM 8.85b) / Revenue TTM)
Gross Margin QoQ = 29.40% (prev 29.78%)
Tobins Q-Ratio = 2.49 (Enterprise Value 8.94b / Total Assets 3.59b)
Interest Expense / Debt = 0.44% (Interest Expense 4.70m / Debt 1.08b)
Taxrate = 6.89% (2.90m / 42.1m)
NOPAT = 249.5m (EBIT 268.0m * (1 - 6.89%))
Current Ratio = 0.88 (Total Current Assets 2.04b / Total Current Liabilities 2.30b)
Debt / Equity = 2.16 (Debt 1.08b / totalStockholderEquity, last quarter 497.9m)
Debt / EBITDA = 0.50 (Net Debt 196.7m / EBITDA 397.3m)
Debt / FCF = 0.35 (Net Debt 196.7m / FCF TTM 562.4m)
Total Stockholder Equity = 433.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.74% (Net Income 222.8m / Total Assets 3.59b)
RoE = 12.42% (Net Income TTM 222.8m / Total Stockholder Equity 1.79b)
RoCE = 11.59% (EBIT 268.0m / Capital Employed (Equity 1.79b + L.T.Debt 518.7m))
RoIC = 55.28% (NOPAT 249.5m / Invested Capital 451.4m)
WACC = 8.25% (E(8.74b)/V(9.82b) * Re(9.21%) + D(1.08b)/V(9.82b) * Rd(0.44%) * (1-Tc(0.07)))
Discount Rate = 9.21% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -51.11 | Cagr: -0.69%
[DCF] Terminal Value 77.97% ; FCFF base≈518.4m ; Y1≈594.3m ; Y5≈874.7m
[DCF] Fair Price = 55.76 (EV 13.2b - Net Debt 196.7m = Equity 13.0b / Shares 232.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 93.30 | EPS CAGR: 60.90% | SUE: -0.18 | # QB: 0
Revenue Correlation: 98.83 | Revenue CAGR: 6.90% | SUE: -0.10 | # QB: 0
EPS current Quarter (2026-07-31): EPS=0.41 | Chg30d=-0.44% | Revisions=+20% | Analysts=14
EPS current Year (2027-01-31): EPS=1.61 | Chg30d=-0.29% | Revisions=-20% | GrowthEPS=+27.2% | GrowthRev=+8.5%
EPS next Year (2028-01-31): EPS=1.96 | Chg30d=-0.30% | Revisions=-20% | GrowthEPS=+21.5% | GrowthRev=+7.9%
[Analyst] Revisions Ratio: +20%